Add Yahoo as a preferred source to see more of our stories on Google. Weather and sea conditions could delay crews getting to the Longships Lighthouse to do the repair - Matt Cardy/Getty Images A ...
FHD-286 is a highly potent, selective, allosteric, and orally available small-molecule, enzymatic inhibitor of BRG1 (SMARCA4) and BRM (SMARCA2), two highly similar proteins that are the ATPases, or ...
Foghorn Therapeutics has been sitting in dock for over a year due to an FDA clinical hold placed on its blood cancer drug in the wake of a patient death. Now, the biotech can set sail once again. A ...
CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by ...
Foghorn Therapeutics, a biotech whose technology can affect one of the ways a cell regulates gene expression, has shown its approach has the potential to address a particular mutation tied to more ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--FogHorn, a leading developer of edge computing AI software for industrial and commercial Internet of Things (IoT) solutions, today announced plans to collaborate ...
Eli Lilly & Co. said Monday it has entered a strategic collaboration with Foghorn Therapeutics Inc. for novel oncology targets using Foghorn's proprietary gene traffic control platform, a move that ...
The foghorn at the South Breakwater Light station, on the ship canal, was quite a presence in Duluth when I was a very little girl. My earliest memory of it, however, was not until just before I ...
FogHorn is a leading developer of edge AI software for industrial and commercial IoT application solutions. FogHorn’s software platform brings the power of advanced analytics and machine learning to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results